ArticleOncotarget2015

Anti-β₂-microglobulin monoclonal antibodies overcome bortezomib resistance in multiple myeloma by inhibiting autophagy.

Mingjun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.